Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person Compound heterozygosity for 2 novel TMEM16F mutations in a patient with Scott syndrome
| Class:Id | LiteratureReference:9853851 |
| _displayName | Compound heterozygosity for 2 novel TMEM16F mutations in a patient with Scott syndrome |
| _timestamp | 2023-11-21 10:33:28 |
| author | [Person:9853803] Castoldi, Elisabetta [Person:9844279] Collins, Peter W [Person:9853843] Williamson, Patrick L [Person:9853820] Bevers, Edouard M |
| created | [InstanceEdit:9853845] Shamovsky, Veronica, 2023-11-21 |
| journal | Blood |
| pages | 4399-400 |
| pubMedIdentifier | 21511967 |
| title | Compound heterozygosity for 2 novel TMEM16F mutations in a patient with Scott syndrome |
| volume | 117 |
| year | 2011 |
| (literatureReference) | [Pathway:9853846] Defective ANO6 does not expose PS, PE on the platelet membrane [Homo sapiens] [FailedReaction:9853849] Defective ANO6 does not expose PS, PE on the platelet membrane [Homo sapiens] [DefinedSet:9853844] ANO6 variant [plasma membrane] [Homo sapiens] [Summation:9854626] In healthy individuals, anoctamin-6 (ANO6, also known as TME... [Summation:9930868] This Reactome event describes the defective scramblase activ... |
|
[Change default viewing format]
|
No pathways have been reviewed or authored by Compound heterozygosity for 2 novel TMEM16F mutations in a patient with Scott syndrome (9853851)